T.Rx Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Synchron's $200M Series B+ round in November 2025, alongside Qatar Investment Authority, Protocol Labs, Neurotechnology Investors and 6 others. That company is in Health and bio.

What T.Rx Capital invests in

• Health and bio · 1 · 100%
• Robotics and hardware · 1 · 100%
• Manufacturing and industrial · 1 · 100%

How T.Rx Capital invests

Share is of the 1 round on Recent Funding that name T.Rx Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

T.Rx Capital portfolio companies

• SSynchron$200MSeries B+ · Nov 2025

Most frequent co-investors

• KKhosla Ventures1 shared round · last Nov 6, 2025
• KK5 Global1 shared round · last Nov 6, 2025
• PProtocol Labs1 shared round · last Nov 6, 2025
• IIQT1 shared round · last Nov 6, 2025
• QQatar Investment Authority1 shared round · last Nov 6, 2025
• NNeurotechnology Investors1 shared round · last Nov 6, 2025
• NNational Reconstruction Fund Corporation1 shared round · last Nov 6, 2025
• MMETIS innovative1 shared round · last Nov 6, 2025
• DDouble Point Ventures1 shared round · last Nov 6, 2025

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• DDeepWork Capital1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists T.Rx Capital, which is a subset of its real portfolio. API: /api/v1/investors/t-rx-capital (get a free API key). More: the most active VC firms and new venture capital funds.